INSULET CORPORATION

Insulet Corporation specializes in the manufacturing of in-vitro diagnostic substances, including reagents, test kits, and diagnostic test sets designed for clinical and point-of-care applications. Their technical expertise lies in the development and production of precision-engineered diagnostic components that meet stringent regulatory standards for accuracy, stability, and batch consistency. The company’s capabilities center on formulation science, sterile manufacturing processes, and quality systems compliant with FDA and CLIA requirements, ensuring reliable performance in diagnostic environments. Their specialization in FSS contract delivery indicates a focus on scalable, standardized diagnostic solutions suitable for federal procurement channels, with an emphasis on rapid deployment and supply chain reliability. The company has demonstrated direct engagement with the Department of Veterans Affairs, providing diagnostic test kits and reagents critical to veteran healthcare services, including laboratory testing and chronic disease management programs. This relationship suggests alignment with VA’s mission to deliver accessible, high-quality diagnostic services across its nationwide network of medical centers and outpatient clinics. Insulet Corporation’s primary industry focus is in the in-vitro diagnostic substance manufacturing sector (NAICS 325413), where they operate as a specialized producer of clinical-grade diagnostic materials. Their market positioning is that of a precision manufacturer serving federal healthcare infrastructure, with an emphasis on reliable, regulated production of consumable diagnostic products rather than device hardware or software integration. As a 2L entity headquartered in Acton, Massachusetts, Insulet Corporation operates as a mid-sized manufacturer with a focused government market presence. The company holds no active federal certifications, but its ability to secure and fulfill a federal supply schedule contract demonstrates compliance with federal quality and procurement standards. Their geographic footprint is centered in New England, with operations tailored to meet the logistical and regulatory demands of federal healthcare procurement.